3.2.4 / April 24, 2019
(4.5/5) (10)
Loading...

Description

The Rotterdam Prostate Cancer Risk Calculator is based on ERSPC,Rotterdam, data and supported by the Prostate Cancer ResearchFoundation, Rotterdam (SWOP). The Prostate Cancer ResearchFoundation, Rotterdam, Stichting Wetenschappelijk OnderzoekProstaatkanker (SWOP), is an initiative of the Department ofUrology of the Erasmus MC, the University and Medical Centre ofRotterdam, in The Netherlands. Its goal is the financial support ofscientific research projects in the field of prostate cancer, aswell as other cancers of the urinary tract. Please be aware thatthe Rotterdam Prostate Cancer Risk Calculator for Android cannot be100% accurate at predicting the presence or absence of prostatecancer. It is designed to help calculate your risk, not give adefinitive diagnosis. The Rotterdam Prostate Cancer Risk Calculatorfor Android provides a general risk calculation based on your PSAlevel and other information. While knowing your PSA level ishelpful, the decision to have a PSA test has to be taken seriouslyafter weighing up all factors and discussing the implications withyour GP or hospital doctor. It is possible that prostate cancerwill not be found even if you have an elevated PSA. However, it maybe present even if your PSA level is low. Your doctor may want totake further tests. If you have doubts or questions about yourhealth, you should always contact your GP or hospital doctor. Thisis particularly important if you have questions which arise fromthe use of our prostate cancer risk calculator. It cannot be ruledout that the way the Rotterdam Prostate Cancer Risk Calculator forAndroid is used, or the indications given by it, are interpreted ina manner that is not appropriate. The creators of the RotterdamProstate Cancer Risk Calculator for Android do not accept anyresponsibility in any respect. The European Randomized Study ofScreening for Prostate Cancer has published its 11-year follow-upresults (New England Journal of Medicine, March 15 2012). Onceagain, they demonstrate that screening does significantly reducedeath from prostate cancer. The latest study confirms that a manwho undergoes PSA testing will have his risk of dying from prostatecancer reduced by 29%. ERSPC is the world’s largest randomizedprostate cancer screening study. It was designed to investigatewhether early detection and treatment of prostate cancer mightreduce disease-specific mortality and also help to identify men atrisk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to69, across Europe to either a screening arm or a control group.Designed and developed for Android by Nuno Azevedo of Ydeal.netSoftware

App Information com.rpcrc

  • App Name
    com.rpcrc
  • Package Name
    com.rpcrc
  • Updated
    April 24, 2019
  • File Size
    2.7M
  • Requires Android
    Android 4.0.3 and up
  • Version
    3.2.4
  • Developer
    SWOP
  • Installs
    100+
  • Price
    $2.43
  • Category
    Medical
  • Developer
    Rochussenstraat 125, kamer NH-224 3015 EJ Rotterdam
  • Google Play Link

SWOP Show More...

com.rpcrc 3.2.4 APK
SWOP
The Rotterdam Prostate Cancer Risk Calculator is based on ERSPC,Rotterdam, data and supported by the Prostate Cancer ResearchFoundation, Rotterdam (SWOP). The Prostate Cancer ResearchFoundation, Rotterdam, Stichting Wetenschappelijk OnderzoekProstaatkanker (SWOP), is an initiative of the Department ofUrology of the Erasmus MC, the University and Medical Centre ofRotterdam, in The Netherlands. Its goal is the financial support ofscientific research projects in the field of prostate cancer, aswell as other cancers of the urinary tract. Please be aware thatthe Rotterdam Prostate Cancer Risk Calculator for Android cannot be100% accurate at predicting the presence or absence of prostatecancer. It is designed to help calculate your risk, not give adefinitive diagnosis. The Rotterdam Prostate Cancer Risk Calculatorfor Android provides a general risk calculation based on your PSAlevel and other information. While knowing your PSA level ishelpful, the decision to have a PSA test has to be taken seriouslyafter weighing up all factors and discussing the implications withyour GP or hospital doctor. It is possible that prostate cancerwill not be found even if you have an elevated PSA. However, it maybe present even if your PSA level is low. Your doctor may want totake further tests. If you have doubts or questions about yourhealth, you should always contact your GP or hospital doctor. Thisis particularly important if you have questions which arise fromthe use of our prostate cancer risk calculator. It cannot be ruledout that the way the Rotterdam Prostate Cancer Risk Calculator forAndroid is used, or the indications given by it, are interpreted ina manner that is not appropriate. The creators of the RotterdamProstate Cancer Risk Calculator for Android do not accept anyresponsibility in any respect. The European Randomized Study ofScreening for Prostate Cancer has published its 11-year follow-upresults (New England Journal of Medicine, March 15 2012). Onceagain, they demonstrate that screening does significantly reducedeath from prostate cancer. The latest study confirms that a manwho undergoes PSA testing will have his risk of dying from prostatecancer reduced by 29%. ERSPC is the world’s largest randomizedprostate cancer screening study. It was designed to investigatewhether early detection and treatment of prostate cancer mightreduce disease-specific mortality and also help to identify men atrisk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to69, across Europe to either a screening arm or a control group.Designed and developed for Android by Nuno Azevedo of Ydeal.netSoftware
Follow MyPSA 1.3 APK
SWOP
The MyPSA app is developed by researchersfromthe department of Urology, Erasmus Medical Center, Rotterdam,theNetherlands and Ydeal.net. The Follow MyPSA app is designedforpatients on active surveillance who wish to be actively involvedintheir disease process. It provides men with the opportunitytomonitor their prostate specific antigen (PSA), managetheirappointments, and amongst others, find further informationaboutprostate cancer. The researchers from the department ofUrology,Erasmus MC have gained tremendous knowledge on activesurveillancefor low-risk prostate cancer, by initiating theProstate cancerResearch International Active Surveillance study(PRIAS) in 2006.PRIAS is an international, multi-center, web-based,observationalstudy which includes over 6,500 patients from 25countries. Atwww.prias-project.org more information can be found onthe studyprotocol and features for medical specialists. Publishedresultsfrom the PRIAS study have led to the acceptance ofactivesurveillance as an effective and safe treatment strategy formenwith low-risk, localized prostate cancer and the inclusion ofthisstrategy in national and international guidelines on thetreatmentof prostate cancer.At www.prias-project.org more information can be found on thestudyprotocol and features for medical specialists. This appis,however, designed for patients on active surveillance who wishtobe actively involved in their disease process. It provides menwiththe opportunity to monitor their prostate specific antigen,managetheir appointments, and amongst others, find furtherinformationabout prostate cancer. Men interested in using the appcan downloadit and engage, being either a PRIAS participant or aman followingactive surveillance outside the PRIAS study.Men on active surveillance and interested in using the appcandownload it and engage! Men who decide to start using the appandrun into difficulties or have suggestions for improvementsarewelcome to share their ideas at [email protected]@prias.me.Designed and developed for Android by Nuno AzevedoofYdeal.net.
Loading...